Pharmaceutical Industry in Japan

Japan’s pharmaceutical industry is facing several challenges making it a critical industry to watch as health care reforms continue and health care needs shift alongside aging of the population.  HGPI’s Executive Director, Toshio Miyata, was featured in this May 2015 Monthly MIX article alongside MHLW’s Health Insurance Bureau Deputy Director-General, Toshihiko Takeda, to discuss recent reforms, their impact on the future of the pharmaceutical industry, and the keys to long-term success of the pharmaceutical industry in Japan.

See the full article here in English:
Monthy MIX May 2015 The Future of the Pharmaceutical Industry in Japan


This article has been made available for use on JHPN by the editors of Monthly MIX.